Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB14752ApprovedSmall moleculeAdrenergic alpha-AgonistsAdrenergic beta-AgonistsAlpha-and Beta-adrenergic AgonistsNorepinephrine Releasing AgentsSympathomimetic (Adrenergic) Agents
Racephedrine: Overview.
- Formula / weight
- C10H15NO · 165.236 g/mol (avg)
- First approval
- Canada, 1998
- Also known as
- (+-)-Ephedrine · Ephedrine DL-form
Resolves to
Structure
InChIKey
KWGRBVOPPLSCSI-PSASIEDQSA-NSMILESCN[C@H](C)[C@@H](O)C1=CC=CC=C1What you can answer from here — as of September 16, 2026
Which companies are running trials of Racephedrine, in which indications and phases, and which of those programs are still active?